Custirsen (OGX-011): a second-generation antisense inhibitor of clusterin in development for the treatment of prostate cancer

By Zielinski Robert   Chi Kim N  

Future Oncology, Vol. 8, Iss. 10, 2012-10 ,pp. : 1239-1251

Future Medicine

Access to resources Recommend Favorite

RL71, a second-generation curcumin analog, induces apoptosis and downregulates Akt in ER-negative breast cancer cells

By        

International Journal of Oncology, Vol. 41, Iss. 3, 2012-01 ,pp. : 1119-1127

Spandidos Publications

Access to resources Recommend Favorite

RL66 a second-generation curcumin analog has potent in vivo and in vitro anticancer activity in ERnegative breast cancer models

By        

International Journal of Oncology, Vol. 41, Iss. 5, 2012-01 ,pp. : 1723-1732

Spandidos Publications

Access to resources Recommend Favorite

Introduction; interferons’ connection to cancer

By Pitha P.M.  

Seminars in Cancer Biology, Vol. 10, Iss. 2, 2000-04 ,pp. : 69-72

Academic Press

Access to resources Recommend Favorite

Carfilzomib: a novel second-generation proteasome inhibitor

By Khan Meaghan L   Stewart A Keith  

Future Oncology, Vol. 7, Iss. 5, 2011-05 ,pp. : 607-612

Future Medicine

Access to resources Recommend Favorite